Longbin Liu Selected Research

Longbin Liu Research Topics

Disease

13	Huntington Disease (Huntington's Disease) 12/2023 - 01/2020
10	Neoplasms (Cancer) 01/2020 - 07/2008
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 04/2020
4	Disease Progression 01/2022 - 01/2020
4	Atherosclerosis 10/2012 - 07/2009
3	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2021
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 04/2020
2	Atherosclerotic Plaque (Atheroma) 06/2010 - 07/2009
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021
1	Newborn Respiratory Distress Syndrome 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Brain Diseases (Brain Disorder) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2018
1	Hyperplasia 01/2016
1	Diabetes Mellitus 12/2013
1	Insulin Resistance 10/2012
1	Carcinogenesis 03/2012
1	Neoplasm Metastasis (Metastasis) 03/2012
1	Hyperhomocysteinemia 06/2010
1	Coronary Disease (Coronary Heart Disease) 07/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2022 - 07/2018
4	polyglutamineIBA 10/2023 - 01/2020
3	Huntingtin ProteinIBA 12/2023 - 09/2023
3	Glycoproteins (Glycoprotein)IBA 10/2022 - 01/2020
2	pyrimidineIBA 12/2023 - 01/2021
2	LigandsIBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 12/2013 - 07/2009
2	Rosuvastatin Calcium (Crestor)FDA Link 10/2012 - 07/2009
2	Insulin (Novolin)FDA Link 10/2012 - 07/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2012 - 09/2012
2	Phosphotransferases (Kinase)IBA 03/2012 - 03/2011
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2010 - 01/2010
2	LDL Receptors (LDL Receptor)IBA 06/2010 - 01/2010
2	Matrix Metalloproteinases (MMPs)IBA 01/2010 - 07/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2008 - 07/2008
1	Glutamine (L-Glutamine)FDA Link 01/2023
1	1- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- oneIBA 01/2022
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Keratin-14 (Keratin 14)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	SCH 23390IBA 01/2021
1	Endothelin-1 (Endothelin 1)IBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 04/2020
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2020
1	Protein AggregatesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	sotorasibIBA 01/2020
1	Niclosamide FDA Link 01/2019
1	nitazoxanide (NTZ)FDA Link 01/2019
1	Angiotensin IIIBA 07/2018
1	IgA receptor (protein B)IBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 12/2013
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2012
1	Insulin Receptor Substrate ProteinsIBA 10/2012
1	CholesterolIBA 10/2012
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2012
1	4- (2- ((6- methoxypyridin- 3- yl)amino)- 5- ((4- (methylsulfonyl)piperazin- 1- yl)methyl)pyridin- 3- yl)- 6- methyl- 1,3,5- triazin- 2- amineIBA 09/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2012
1	Proto-Oncogene Proteins c-metIBA 03/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2012
1	pyrazoloneIBA 03/2012
1	Methionine (L-Methionine)FDA Link 06/2010
1	Ethanol (Ethyl Alcohol)IBA 06/2010
1	Heparin (Liquaemin)FDA LinkGeneric 01/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2009
1	LipidsIBA 07/2009

Therapy/Procedure

7	Therapeutics 01/2022 - 07/2009
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021